## Abstract Receptor activator of NF‐κB ligand (RANKL) has been identified as requisite for osteoclastogenesis. To elucidate the molecular mechanism that conducts its catabolic action on bone, the effect of 1α,25 dihydroxyvitamin D~3~ (1α,25(OH)~2~D~3~) on osteoclastogenesis and RANKL mRNA expressi
Modulation of mouse RANKL gene expression by Runx2 and vitamin D3
✍ Scribed by Riko Kitazawa; Kiyoshi Mori; Akira Yamaguchi; Takeshi Kondo; Sohei Kitazawa
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 354 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The expression of receptor activator of nuclear factor‐κB ligand (RANKL) is regulated by bone‐seeking hormones such as PTH and 1α,25‐dihydroxyvitamin D~3~ (1,25(OH)~2~D~3~). Runx2, a master gene for osteoblastic differentiation, also modulates osteoclastogenesis by regulating the RANKL gene. To elucidate the mechanism whereby runx2 and 1,25(OH)~2~D~3~ regulate RANKL expression, we studied the function of runx2 on the chromatin structure and on the proximal binding sites using osteoblastic cell lines derived from normal (ST2) and runx2‐deficient mice (RD‐C6). Although the expression of RANKL in the steady‐state was higher in RD‐C6 than in ST2, 1,25(OH)~2~D~3~‐treatment of the cells increased it 20‐fold in ST2 but only 1.8‐fold in RD‐C6. Transient transfection studies with proximal RANKL 2kb promoter, runx2 knock‐down in ST2, and forced expression of runx2 in RD‐C6 all confirmed that runx2 set the steady‐state expression of the RANKL gene at a low level, but exerted a positive effect on enhanced transcriptional activity in response to 1,25(OH)~2~D~3~. Also, assessment of the acetylation status of the area spanning 40 kb upstream of the basic promoter in ST2 and RD‐C6 by ChIP assay revealed that whereas H3 and H4 histone acetylation was detected even in the steady‐state in RD‐C6, it was detected only with 1,25(OH)~2~D~3~ in ST2. In the steady‐state, runx2 may suppress RANKL gene by condensing the chromatin structure; however, it exerts a positive effect on 1,25(OH)~2~D~3~‐induced RANKL transcription when the proximal runx2 sites are accessible. Thus, RANKL expression in stromal/osteoblastic cells is keenly regulated by 1,25(OH)~2~D~3~ which transactivates the gene at two different levels. J. Cell. Biochem. 105: 1289–1297, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Core binding factor alpha 1 (Cbfa1) is an osteoblast-specific transcription factor essential to develop a mature osteoblast phenotype. However, its exact role in the signaling of various osteotropic-differentiating agents is still unclear. In this study, we assessed the effects of 1,25-(OH)(2)-D3 (D
## Abstract The vitamin D receptor (VDR) is a member of the steroid/retinoid receptor superfamily of nuclear receptors and has potential tumor‐suppressive functions in prostate and other cancer types. Vitamin D~3~ (VD~3~) exerts its biological actions by binding within cells to VDR. The VDR then in
## Abstract T‐box (Tbx)3, a known transcriptional repressor, is a member of a family of transcription factors, which contain a highly homologous DNA binding domain known as the Tbx domain. Based on the knowledge that mutation of the Tbx3 gene results in limb malformation, Tbx3 regulates osteoblast
The matrix-degrading enzyme family of matrix-metalloproteinases (MMPs) has been implicated in the process of tumour metastasis. Cellular protein and RNA localisation techniques have been used to show that, whilst several MMP genes are expressed in both cancer and stromal cells, stromelysin 3 is expr